1.National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2003. Am J Infect Control 2003;31:481–498.
2.Gastmeier, P, Sohr, D, Geffers, C, Nassauer, A, Dettenkofer, M, Ruden, H. Occurrence of methicillin-resistant Staphylococcus aureus infections in German intensive care units. Infection 2002; 30:198–202.
3.Herr, CE, Heckrodt, TH, Hofmann, FA, Schnettler, R, Eikmann, TF. Additional costs for preventing the spread of methicillin-resistant Staphylococcus aureus and a strategy for reducing these costs on a surgical ward. Infect Control Hosp Epidemiol 2003; 24:673–678.
4.Kresken, M, Hafner, D, Schmitz, FJ, Wichelhaus, TA. Resistenzsituation bei klinisch wichtigen Infektionserregern gegenüber Antibiotika in Deutschland und im mitteleuropäischen Raum. Bonn, Germany: Antiinfectives Intellegence; 2003.
5.Thompson, RL, Cabezudo, I, Wenzel, RP. Epidemiology of nosocomial infections caused by methicillin-resistant Staphylococcus aureus. Ann Intern Med 1982; 97:309–317.
6.Fridkin, SK, Steward, CD, Edwards, JR, et al. Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals. Clin Infect Dis 1999; 29:245–252.
7.Wertheim, HF, Vos, MC, Boelens, HA, et al. Low prevalence of methicillin-resistant Staphylococcus aureus (MRSA) at hospital admission in The Netherlands: the value of search and destroy and restrictive antibiotic use. J Hosp Infect 2004; 56:321–325.
8.Monnet, DL, Frimodt-Moller, N. Antimicrobial-drug use and methicillin-resistant Staphylococcus aureus. Emerg Infect Dis 2001; 7:161–163.
9.Monnet, DL. Methicillin-resistant Staphylococcus aureus and its relationship to antimicrobial use: possible implications for control. Infect Control Hosp Epidemiol 1998; 19:552–559.
10.Weber, SG, Gold, HS, Hooper, DC, Karchmer, AW, Carmeli, Y. Fluoroquinolones and the risk for methicillin-resistant Staphylococcus aureus in hospitalized patients. Emerg Infect Dis 2003; 9:1415–1422.
11.Archibald, L, Phillips, L, Monnet, D, McGowan, JE Jr, Tenover, F, Gaynes, R. Antimicrobial resistance in isolates from inpatients and outpatients in the United States: increasing importance of the intensive care unit. Clin Infect Dis 1997;24:211–215.
12.Gastmeier, P, Geffers, C, Sohr, D, Dettenkofer, M, Daschner, F, Ruden, H. Five years working with the German nosocomial infection surveillance system (Krankenhaus Infektions Surveillance System). Am J Infect Control 2003;31:316–321.
13.German Industrial Standard (DIN). Methods for the Determination of Susceptibility of Pathogens (Except Mycobacteria) to Antimicrobial Agents. Part 4. Evaluation Classes of the Minimum Inhibitory Concentration. Berlin: Beuth Verlag; 1998:1–11. DIN number 58940-4.
14.NCCLS. Performance Standards for Antimicrobial Susceptibility Testing. Wayne, PA; 1999. NCCLS document M100-S9.
15.Meyer, E, Jonas, D, Schwab, F, Rueden, H, Gastmeier, P, Daschner, FD. Design of a surveillance system of antibiotic use and bacterial resistance in German intensive Care units (SARI). Infection 2003; 31:208–215.
16.Meyer, E, Schwab, F, Jonas, D, Rueden, H, Gastmeier, P, Daschner, FD. Surveillance of antimicrobial use and antimicrobial resistance in intensive care units (SARI): 1. Antimicrobial use in German intensive care units. Intensive Care Med 2004; 30:1089–1096.
17.Zuschneid, I, Geffers, C, Sohr, D, Kohlhase, C, Schumacher, M, Gastmeier, P, Ruden, H. Accuracy of diagnosing nosocomial infections (NI) within the intensive care unit component of the German Surveillance System and correlations between findings and structural or process variables. In: Program and abstracts of the 13th Annual Scientific Meeting of the Society for Healthcare Epidemiology of America; April 2003; Arlington, VA. Abstract 18.
18.Crowcroft, NS, Ronveaux, O, Monnet, DL, Mertens, R. Methicillin-resistant Staphylococcus aureus and antimicrobial use in Belgian hospitals. Infect Control Hosp Epidemiol 1999; 20:31–36.
19.Loeffler, JM, Garbino, J, Lew, D, Harbarth, S, Rohner, P. Antibiotic consumption, bacterial resistance and their correlation in a Swiss university hospital and its adult intensive care units. Scand J Infect Dis 2003; 35: 843–850.
20.European Antimicrobial Resistance Surveillance System (EARSS). EARSS Annual Report 2002. Bilthoven, The Netherlands: National Institute of Public Health and the Environment; 2004.
21.Fridkin, SK, Hill, HA, Volkova, NV, et al. Temporal changes in prevalence of antimicrobial resistance in 23 US Hospitals. Emerg Infect Dis 2002; 8:697–701.
22.National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 to June 2002, issued August 2002. Am J Infect Control 2002; 30:458–475.
23.Bisognano, C, Vaudaux, P, Rohner, P, Lew, DP, Hooper, DC. Induction of fibronectin-binding proteins and increased adhesion of quinolone-resistant Staphylococcus aureus by subinhibitory levels of ciprofloxacin. Antimicrob Agents Chemother 2000; 44:1428–1437.
24.Westh, H, Zinn, CS, Rosdahl, VT. An international multicenter study of antimicrobial consumption and resistance in Staphylococcus aureus isolates from 15 hospitals in 14 countries. Microb Drug Resist 2004; 10: 169–176.
25.Lopez-Lozano, JM, Monnet, DL, Yague, A, et al. Modelling and forecasting antimicrobial resistance and its dynamic relationship to antimicrobial use: a time series analysis. Int J Antimicrob Agents 2000; 14:21–31.
26.Monnet, D, MacKenzie, F, López-Lozano, JM, et al. Antimicrobial drug use and methicillin-resistant Staphylococcus aureus, Aberdeen, 1996-2000. Emerg Infect Dis 2004; 10:1432–1441.
27.Monnet, DL, Lopez-Lozano, JM, Campillos, P, Burgos, A, Yague, A, Gonzalo, N. Making sense of antimicrobial use and resistance surveillance data: application of ARIMA and transfer function models. Clin Microbiol Infect 2001; 7(Suppl 5):29–36.
28.Talon, D, Muller, A, Thouverez, M, Bertrand, X. MRSA incidence as an indicator of infection control practices: do the results reflect the reality? J Hosp Infect 2004; 57:265–266.
29.Leegaard, TM, Caugant, DA, Froholm, LO, Hoiby, EA. Apparent differences in antimicrobial susceptibility as a consequence of national guidelines. Clin Microbiol Infect 2000; 6:290–293.